Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands |
12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||||||||
| Revenue: | |||||||||||||
| Total revenue | [1] | $ 2,023,994 | $ 1,473,856 | $ 1,333,470 | |||||||||
| Cost of revenue: | |||||||||||||
| Total cost of revenue | [2] | 1,436,594 | 1,069,208 | 1,135,676 | |||||||||
| Gross profit | 587,400 | 404,648 | 197,794 | ||||||||||
| Operating expenses: | |||||||||||||
| Research and development | 185,993 | 148,629 | 155,865 | ||||||||||
| Sales and marketing | 130,228 | 68,005 | 89,961 | ||||||||||
| General and administrative | [3] | 198,377 | 165,105 | 160,875 | |||||||||
| Total operating expenses | 514,598 | 381,739 | 406,701 | ||||||||||
| Income (loss) from operations | 72,802 | 22,909 | (208,907) | ||||||||||
| Interest income | 34,070 | 25,342 | 19,885 | ||||||||||
| Interest expense | [4] | (53,888) | (62,636) | (108,299) | |||||||||
| Equity in loss of unconsolidated affiliates | [5] | (40,421) | 0 | 0 | |||||||||
| Other income (expense), net | 2,151 | 15,904 | (2,793) | ||||||||||
| Loss on extinguishment of debt | (32,340) | (27,182) | (4,288) | ||||||||||
| Debt conversion inducement expense | (66,241) | 0 | 0 | ||||||||||
| Loss on revaluation of embedded derivatives | (537) | (694) | (1,641) | ||||||||||
| Loss before income taxes | (84,404) | (26,357) | (306,043) | ||||||||||
| Income tax provision | 2,736 | 846 | 1,894 | ||||||||||
| Net loss | (87,140) | (27,203) | (307,937) | ||||||||||
| Less: Net income (loss) attributable to noncontrolling interest | 1,294 | 2,024 | (5,821) | ||||||||||
| Net loss attributable to common stockholders | $ (88,434) | $ (29,227) | $ (302,116) | ||||||||||
| Net loss per share available to common stockholders, basic (in dollars per share) | $ (0.37) | $ (0.13) | $ (1.42) | ||||||||||
| Net loss per share available to common stockholders, diluted (in dollars per share) | $ (0.37) | $ (0.13) | $ (1.42) | ||||||||||
| Weighted average shares used to compute net loss per share available to common stockholders, basic (in shares) | 240,402 | 227,365 | 212,681 | ||||||||||
| Weighted average shares used to compute net loss per share available to common stockholders, diluted (in shares) | 240,402 | 227,365 | 212,681 | ||||||||||
| Product | |||||||||||||
| Revenue: | |||||||||||||
| Total revenue | [1] | $ 1,531,281 | $ 1,085,153 | $ 975,245 | |||||||||
| Cost of revenue: | |||||||||||||
| Total cost of revenue | [2] | 992,841 | 685,847 | 630,105 | |||||||||
| Installation | |||||||||||||
| Revenue: | |||||||||||||
| Total revenue | [1] | 204,068 | 122,318 | 92,796 | |||||||||
| Cost of revenue: | |||||||||||||
| Total cost of revenue | [2] | 205,946 | 129,446 | 105,735 | |||||||||
| Service | |||||||||||||
| Revenue: | |||||||||||||
| Total revenue | [1] | 228,295 | 213,542 | 183,065 | |||||||||
| Cost of revenue: | |||||||||||||
| Total cost of revenue | [2] | 205,389 | 214,961 | 220,927 | |||||||||
| Electricity | |||||||||||||
| Revenue: | |||||||||||||
| Total revenue | [1] | 60,350 | 52,843 | 82,364 | |||||||||
| Cost of revenue: | |||||||||||||
| Total cost of revenue | [2] | $ 32,418 | $ 38,954 | $ 178,909 | |||||||||
| |||||||||||||
| X | ||||||||||
- Definition Embedded Derivative, Gain (Loss) On Embedded Derivative, Net, And Fair Value Adjustment Of Warrants No definition available.
|
| X | ||||||||||
- Definition Net Income (Loss) Attributable To Parent, Including Redeemable Noncontrolling Interest No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for inducement to convert debt instrument representing fair value of security and other consideration transferred in excess of fair value of security and other consideration issuable pursuant to conversion privilege provided in terms of existing instrument. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|